Essex Woodlands Health Ventures

Latest statistics and disclosures from Essex Woodlands Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are MDXG, BVS, EYPT, TELA, RVNC, and represent 99.32% of Essex Woodlands Management's stock portfolio.
  • Added to shares of these 1 stock: VERO.
  • Started 1 new stock position in VERO.
  • Reduced shares in these 2 stocks: EYPT (-$16M), Venus Concept.
  • Sold out of its position in Venus Concept.
  • Essex Woodlands Management was a net seller of stock by $-17M.
  • Essex Woodlands Management has $345M in assets under management (AUM), dropping by -14.67%.
  • Central Index Key (CIK): 0001542339

Tip: Access up to 7 years of quarterly data

Positions held by Essex Woodlands Health Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Essex Woodlands Management

Essex Woodlands Management holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
MiMedx (MDXG) 63.0 $217M 28M 7.70
 View chart
Bioventus Com Cl A (BVS) 19.6 $68M 13M 5.20
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 9.3 $32M -33% 1.6M 20.67
 View chart
Tela Bio (TELA) 6.8 $23M 4.1M 5.67
 View chart
Revance Therapeutics (RVNC) 0.7 $2.2M 457k 4.92
 View chart
Medicinova Com New (MNOV) 0.5 $1.6M 1.1M 1.45
 View chart
Venus Concept (VERO) 0.2 $753k NEW 1.1M 0.69
 View chart

Past Filings by Essex Woodlands Management

SEC 13F filings are viewable for Essex Woodlands Management going back to 2011

View all past filings